Insiders · MLYS

Eric Warren

Chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS) since March 2026

Eric Warren has filed 42 insider reports with the SEC since March 2022, as chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS) and chief Commercial Officer at Esperion Therapeutics, Inc. (ESPR). In the last 12 months Eric Warren sold $3.3M of stock on the open market. On September 21, 2026 Eric Warren filed a Form 144 notice and plans to sell 7,438 MLYS shares (~$209K). In the latest filing, on September 22, 2026, Eric Warren sold 7,438 shares of Mineralys Therapeutics, Inc. (MLYS) for $209K at an average of $28.12.

Planned sale (Form 144)

  • Eric Warren plans to sell 7,438 MLYS shares (~$209K), around Sep 21, 2026. Notice filed Sep 21, 2026.

A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.

Filings
42
Companies
2
Bought on market
$7,460
Sold on market
$3.36M

Companies where Eric Warren is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Mineralys Therapeutics, Inc. logo
MLYS
Mineralys Therapeutics, Inc.
Chief Commercial Officersince March 202638,400$3.3M$14.16Sep 22, 2026
Esperion Therapeutics, Inc. logo
ESPR
Esperion Therapeutics, Inc.
Chief Commercial Officersince March 2022370,218$7,460$61.4K$7.46Apr 21, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Warren with

Other insiders at the same companies

Questions about Eric Warren

What is Eric Warren's role at Mineralys Therapeutics, Inc.?
Eric Warren reports to the SEC as chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS), according to the latest filing on September 22, 2026. Eric Warren has also filed as chief Commercial Officer at Esperion Therapeutics, Inc. (ESPR).
How many shares does Eric Warren own?
After the latest filing that states it, Eric Warren directly owned 38,400 shares of Mineralys Therapeutics, Inc. (MLYS) and 370,218 shares of Esperion Therapeutics, Inc. (ESPR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eric Warren bought or sold stock recently?
The most recent open-market purchase was on August 31, 2022: bought 1,000 shares of Esperion Therapeutics, Inc. (ESPR) for $7,460 at an average of $7.46. The most recent open-market sale was on September 21, 2026: sold 7,438 shares of Mineralys Therapeutics, Inc. (MLYS) for $209K at an average of $28.12.
How do I get alerts when Eric Warren files?
Follow Eric Warren on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Eric Warren filed 3 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Eric Warren (SEC CIK 0001916048). Totals count each trade once, skipping amendments whose original is on file, from Mar 9, 2022 on. View on SEC EDGAR · Get this as JSON